Alimera Sciences Inc. - notizie pubblicate 237 - letture 2.927
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ALIMERA SCIENCES INC.
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Form 8-K
Alimera sciences names elliot maltz as chief financial officer and reports inducement grant under nasdaq listing rule 5635(c)(4) atlanta, january 2, 2024 -- alimera sciences, inc. ...
ALIMERA SCIENCES INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ALIMERA SCIENCES INC.
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Form 8-K
Alimera sciences names elliot maltz as chief financial officer and reports inducement grant under nasdaq listing rule 5635(c)(4) atlanta, january 2, 2024 -- alimera sciences, inc. ...
ALIMERA SCIENCES INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ALIMERA SCIENCES INC.
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Form 8-K
Alimera sciences names elliot maltz as chief financial officer and reports inducement grant under nasdaq listing rule 5635(c)(4) atlanta, january 2, 2024 -- alimera sciences, inc. ...
ALIMERA SCIENCES INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ALIMERA SCIENCES INC.
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Form 8-K
Alimera sciences names elliot maltz as chief financial officer and reports inducement grant under nasdaq listing rule 5635(c)(4) atlanta, january 2, 2024 -- alimera sciences, inc. ...
ALIMERA SCIENCES INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
ALIMERA SCIENCES INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ALIMERA SCIENCES INC.
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Form 8-K
Alimera sciences names elliot maltz as chief financial officer and reports inducement grant under nasdaq listing rule 5635(c)(4) atlanta, january 2, 2024 -- alimera sciences, inc. ...
ALIMERA SCIENCES INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti